Epidemiology of diabetes and its non-coronary complications

被引:74
作者
Goday, A [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Mar, Serv Endocrinol, E-08003 Barcelona, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2002年 / 55卷 / 06期
关键词
diabetes mellitus; incidence; prevalence; Spain;
D O I
10.1016/S0300-8932(02)76674-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is among the diseases with great impact on health and society, not only for its high prevalence but also for its chronic complications and high mortality. The most precise method to investigate the prevalence of diabetes is by oral glucose tolerance testing. In Spain, the prevalence of diabetes in the 30-65 year-old population is estimated to be 6.5% among 30-to-65- year old, and 10.3% among the 30-to-89 year-old population. The ratio of known to unknown diabetes ranges from 1:3 to 2:3. The incidence of diabetes mellitus type 2 in Spain is 8/1000 persons per year, and the incidence of type 1 is 11 to 12 cases per 100,000 persons per year. The prevalence of chronic complications varies according to type of diabetes, time since onset and degree of metabolic control: neuropathy 25%, retinopathy 32% and nephropathy 23%. Diabetes is one of the most important causes of death in Spain, occupying third place for women and seventh for men.
引用
收藏
页码:657 / 670
页数:14
相关论文
共 144 条
[1]   Effect of socioeconomic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh [J].
AbuSayeed, M ;
Ali, L ;
Hussain, MZ ;
Rumi, MAK ;
Banu, A ;
Khan, AKA .
DIABETES CARE, 1997, 20 (04) :551-555
[2]   PROBLEMS RELATED TO DEFINITIONS AND EPIDEMIOLOGY OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS - STUDIES THROUGHOUT THE WORLD [J].
ALBERTI, KGMM .
DIABETOLOGIA, 1993, 36 (10) :978-984
[3]  
Alberti KGMM, 1998, DIABETES RES CLIN PR, V40, pS3
[4]  
Amenábar JJ, 2000, NEFROLOGIA, V20, P34
[5]   PREVALENCE AND INCIDENCE OF DIABETES IN A SWEDISH COMMUNITY 1972-1987 [J].
ANDERSSON, DKG ;
SVARDSUDD, K ;
TIBBLIN, G .
DIABETIC MEDICINE, 1991, 8 (05) :428-434
[6]  
Baena Diez J M, 1999, Aten Primaria, V24, P97
[7]  
Bayo J, 1996, MED CLIN-BARCELONA, V107, P572
[8]  
BAYO J, 1993, MED CLIN-BARCELONA, V101, P609
[9]  
BENNETT PH, 1992, INT TXB DIABETES MEL, P147
[10]  
Björntorp P, 1999, DRUGS, V58, P13